4‐Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll‐like receptor of macrophages and M1 macrophage polarization

[1]  Dong-Hyun Kim,et al.  Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance. , 2016, Journal of ethnopharmacology.

[2]  Wei Zhu,et al.  Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype. , 2016, International immunopharmacology.

[3]  J. Triantafillidis,et al.  Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies , 2016, Annals of gastroenterology.

[4]  Dong-Hyun Kim,et al.  Oleanolic acid ameliorates dextran sodium sulfate-induced colitis in mice by restoring the balance of Th17/Treg cells and inhibiting NF-κB signaling pathway. , 2015, International immunopharmacology.

[5]  Xuetao Cao,et al.  The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. , 2014, Journal of autoimmunity.

[6]  F. Cominelli,et al.  Cytokines and mucosal immunity , 2014, Current opinion in gastroenterology.

[7]  Dong-Hyun Kim,et al.  Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages. , 2014, Journal of agricultural and food chemistry.

[8]  Dong-Hyun Kim,et al.  Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. , 2014, International immunopharmacology.

[9]  A. Bapodra,et al.  Ethno botanical and Phytophrmacological potential of Abrus precatorius L.: A review. , 2014, Asian Pacific journal of tropical biomedicine.

[10]  G. Corazza,et al.  Innate and adaptive immunity in inflammatory bowel disease. , 2014, Autoimmunity reviews.

[11]  Jie-Oh Lee,et al.  Recognition of lipopolysaccharide pattern by TLR4 complexes , 2013, Experimental & Molecular Medicine.

[12]  I. Qureshi,et al.  Antioxidant and antiproliferative activities of Abrus precatorius leaf extracts - an in vitro study , 2013, BMC Complementary and Alternative Medicine.

[13]  A. Salminen,et al.  Phytochemicals suppress nuclear factor-&kgr;B signaling: impact on health span and the aging process , 2012, Current opinion in clinical nutrition and metabolic care.

[14]  B. Foxwell,et al.  NF-κ B and its relevance to arthritis and inflammation , 2012 .

[15]  Caiguo Huang,et al.  A New Triterpenoid Saponin from Abrus precatorius Linn , 2011, Molecules.

[16]  M. Ingersoll,et al.  Monocyte trafficking in acute and chronic inflammation. , 2011, Trends in immunology.

[17]  Dong-Hyun Kim,et al.  Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation. , 2011, Biochemical pharmacology.

[18]  Anita Tilwari,et al.  Immunomodulatory activity of the aqueous extract of seeds of Abrus precatorius Linn (Jequirity) in mice. , 2011, Iranian journal of immunology : IJI.

[19]  D. J. Taur,et al.  Mast cell stabilizing and antiallergic activity of Abrus precatorius in the management of asthma. , 2011, Asian Pacific journal of tropical medicine.

[20]  M. Abdollahi,et al.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. , 2010, World journal of gastroenterology.

[21]  G. Yue,et al.  Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. , 2007, World journal of gastroenterology.

[22]  Kevin Allardyce,et al.  The good cop , 2007 .

[23]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.

[24]  Ines Lindner.  Signalling , 2006, Biologia Plantarum.

[25]  E. Morand.  New therapeutic target in inflammatory disease: macrophage migration inhibitory factor , 2005, Internal medicine journal.

[26]  Zhijian J. Chen,et al.  TRAF2: A Double-Edged Sword? , 2005, Science's STKE.

[27]  D. Kalman,et al.  Initiation and resolution of mucosal inflammation , 2004, Immunologic research.

[28]  R. Yadava,et al.  A new biologically active flavonol glycoside from the seeds of Abrus precatorius Linn , 2002, Journal of Asian natural products research.

[29]  A. Kinghorn,et al.  New Triterpenoids from the Leaves of Abrus Precatorius , 2002, Natural product letters.

[30]  B. Sands.  Novel therapies for inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.

[31]  L. H. Chen,et al.  Potent antiplatelet, anti-inflammatory and antiallergic isoflavanquinones from the roots of Abrus precatorius. , 1995, Planta medica.

[32]  G. Trinchieri,et al.  Cytokine cross‐talk between phagocytic cells and lymphocytes: Relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity , 1993, Journal of cellular biochemistry.

[33]  Ashok K. Singhai Nabin C.Barua Ram P.Sha.  A chalcone and an isoflavone from Millettia pachycarpa seeds , 1983 .